Losartan (all presentations): Supply issue

Supply issue Active

Supplies of losartan 25 mg are exhausted. Other presentations (including with hydrochlorothiazide) are available.

Update 5 May 2022

12.5 mg resolved. Further shipments of the 25 mg are expected May and June.

Supply status

12.5 mg supply issue resolved

We are advised that supplies losartan 12.5 mg (pharmacode 2466856) are available again.

25 mg deliveries expected

Teva, the supplier of losartan, advises that there will be shipments of this presentation (pharmacode 2466864) in mid-May and early June. 

There is ample supply of the 50 mg, 100 mg presentations and losartan with hydrochlorothiazide. 

Alternative product

We have been advised that funded alternatives include candesartan. There are ample supplies of candesartan.

Candesartan Schedule listing(external link)

Candesartan monograph - NZ Formulary(external link) (includes dosing information)

Who to contact

If you take losartan in either the 12.5 mg or 25 mg presentations, talk to your pharmacist or the person who prescribed it to you. They know you best and may recommend an alternative funded medication. Pharmac cannot give clinical advice to any individual person.

If you have questions about funding, email enquiry@pharmac.govt.nz

If you have questions about the availablility of these medicines, contact Teva Pharmaceuticals(external link)